Get the Stockscreener App
1.17
5.65%
-0.07
Pre-market:
1.14
-0.03
-2.56%
Geovax Labs Inc stock is traded at $1.17, with a volume of 463.84K.
It is down -5.65% in the last 24 hours and down -20.41% over the past month.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
See More
Previous Close:
$1.24
Open:
$1.21
24h Volume:
463.84K
Relative Volume:
3.71
Market Cap:
$3.38M
Revenue:
$2.49M
Net Income/Loss:
$-21.46M
P/E Ratio:
-0.0599
EPS:
-19.526
Net Cash Flow:
$-21.50M
1W Performance:
-8.59%
1M Performance:
-20.41%
6M Performance:
-92.17%
1Y Performance:
-94.36%
1-Day Range:
$1.135
$1.22
1-Week Range:
$1.135
$1.35
52-Week Range:
$1.135
$34.75
Geovax Labs Inc Stock (GOVX) Company Profile
Name
Geovax Labs Inc
Sector
Industry
Phone
678-384-7220
Address
1955 LAKE PARK DRIVE, SMYRNA
Compare GOVX vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GOVX
Geovax Labs Inc
|
1.17 | 3.59M | 2.49M | -21.46M | -21.50M | -19.53 |
VRTX
Vertex Pharmaceuticals Inc
|
439.18 | 112.22B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.41 | 79.35B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
834.45 | 52.80B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
310.94 | 41.32B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
318.07 | 35.95B | 5.36B | 287.73M | 924.18M | 2.5229 |
Geovax Labs Inc Stock (GOVX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-19-26 | Downgrade | D. Boral Capital | Buy → Hold |
| Apr-15-25 | Reiterated | Alliance Global Partners | Buy |
| Apr-15-25 | Reiterated | D. Boral Capital | Buy |
| Nov-11-24 | Initiated | Alliance Global Partners | Buy |
| Jul-16-24 | Initiated | ROTH MKM | Buy |
| Nov-19-20 | Initiated | Maxim Group | Buy |
View All
Geovax Labs Inc Stock (GOVX) Latest News
[EFFECT] GeoVax Labs, Inc. SEC Filing - Stock Titan
GeoVax Labs (NASDAQ: GOVX) adds auditor consent in S-1 amendment - Stock Titan
[POS EX] GeoVax Labs, Inc. SEC Filing - Stock Titan
GOVX Forecast, Price Target & Analyst Ratings | GEOVAX LABS INC (NASDAQ:GOVX) - ChartMill
GeoVax Labs (NASDAQ: GOVX) seeks votes to approve Feb/March 2026 warrant exercises - Stock Titan
GOVX Maintained by D. Boral Capital -- Price Target Steady at $1 - GuruFocus
GOVX Technical Analysis | Trend, Signals & Chart Patterns | GEOVAX LABS INC (NASDAQ:GOVX) - ChartMill
GeoVax Labs, Inc. Files Form 8-K with Nasdaq: Company Details, Financial Highlights, and Key Disclosures - Minichart
GeoVax Labs, Inc. 2024 Annual Report: Clinical Pipeline, Business Overview, Risks, and Intellectual Property Strategies - Minichart
GeoVax Reports 2025 Year-End Financial Results and Provides Business Update - National Today
GeoVax Labs (NASDAQ: GOVX) resale of 2.27M warrant shares, no issuer proceeds - Stock Titan
GeoVax Labs (NASDAQ: GOVX) investors face going concern, dilution risks - Stock Titan
GeoVax Advances Mpox/Smallpox Vaccine Toward Phase 3 Trial Amid Global Supply Concerns - citybuzz -
Form 8-KCurrent report - ADVFN
GeoVax Labs Inc reports results for the quarter ended December 31Earnings Summary - TradingView
GeoVax Labs (NASDAQ: GOVX) details vaccine pipeline and flags going concern risk - Stock Titan
GeoVax Labs, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
How The GeoVax Labs (GOVX) Story Is Shifting After The Rating Downgrade And Valuation Reset - Yahoo Finance
GeoVax Positions GEO-MVA to Address Supply Constraints in Global Mpox and Smallpox Vaccine Market - Yahoo Finance
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) - ADVFN
Amended Statement of Ownership (sc 13g/a) - ADVFN
Post-effective Amendment to Registration Statement (pos Am) - ADVFN
Annual Report (10-k) - ADVFN
Quarterly Report (10-q) - ADVFN
Form 10-QQuarterly report [Sections 13 or 15(d)] - ADVFN
Forecast Cut: What is the long term forecast for GeoVax Labs Inc Equity Warrant stock2026 WrapUp & Smart Swing Trading Techniques - baoquankhu1.vn
GOVX|GeoVax Labs Inc|Price:1.230|Chg%:0.07 - TradingKey
Noble Financial Maintains GeoVax Labs(GOVX.US) With Buy Rating, Cuts Target Price to $10 - Moomoo
12 Health Care Stocks Moving In Wednesday's After-Market Session - Sahm
Movement Recap: How much upside does GeoVax Labs Inc Equity Warrant have2026 Technicals & Short-Term Swing Trade Alerts - baoquankhu1.vn
Published on: 2026-04-09 02:29:52 - baoquankhu1.vn
Gains Report: What is the long term forecast for GeoVax Labs Inc Equity Warrant stockRate Cut & Intraday High Probability Alerts - baoquankhu1.vn
Momentum Shift: What is GeoVax Labs Incs valuation compared to sectorWeekly Market Summary & Growth Oriented Trading Recommendations - baoquankhu1.vn
GeoVax Highlights Single-Dose Mpox Vaccine Data at World Vaccine Congress 2026 - Yahoo Finance
Geovax Labs Inc (E8LA.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada
GeoVax Labs Boosts Liquidity Through Warrant Inducement Financing - TipRanks
GeoVax Labs Delays Annual 10-K Filing - TipRanks
GeoVax Secures $863,000 Through Warrant Inducement Transaction to Fund Vaccine and Immunotherapy Development - citybuzz -
[8-K] GeoVax Labs, Inc. Reports Material Event - Stock Titan
[NT 10-K] GeoVax Labs, Inc. SEC Filing - Stock Titan
GeoVax Announces a Warrant Inducement Transaction - TradingView
Why The GeoVax Labs (GOVX) Story Is Shifting As Valuation Holds And Risks Rise - Yahoo Finance
Aug Summary: What is GeoVax Labs Incs valuation compared to sector2026 Stock Rankings & Safe Entry Point Identification - baoquankhu1.vn
Investment Review: Is GeoVax Labs Inc Equity Warrant a play on infrastructure spendingGold Moves & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Published on: 2026-03-30 03:13:45 - baoquankhu1.vn
GOVX Should I Buy - Intellectia AI
VIX Spike: Is GeoVax Labs Inc Equity Warrant benefiting from interest rate changesPortfolio Return Summary & Community Verified Watchlist Alerts - baoquankhu1.vn
GeoVax Advances Mpox and Smallpox Vaccine Toward Phase 3 Trial with Clinical Supply Milestone - citybuzz -
Panic Selling: Does GeoVax Labs Inc Equity Warrant align with a passive investing strategy2026 Trading Volume Trends & Accurate Buy Signal Notifications - baoquankhu1.vn
GeoVax Provides Update on GEO-MVA Program - Yahoo Finance
Ideas Watch: Is GeoVax Labs Inc Equity Warrants ROE strong enoughPortfolio Performance Summary & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Geovax Labs Inc Stock (GOVX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):